Brief: Biogen Says DZP Plus Soc Meets Primary Endpoint Of BICLA Response At Week 48
Mon 06:02
BRIEF-Biogen Says DZP Plus Soc Meets Primary Endpoint Of BICLA Response At Week 48 Nov 9 (Reuters) - Biogen Inc. BIIB.O:
BIOGEN - DZP PLUS SOC MEETS PRIMARY ENDPOINT OF BICLA RESPONSE AT WEEK 48; SRI-4 RESPONSE 60% VERSUS 41%
Source text: ID:nGNE8cVSdd
Further company coverage: BIIB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biogen
See all newsUS RESEARCH ROUNDUP-Autodesk, Metlife, Rollins
Brief: Biogen Says DZP Plus Soc Meets Primary Endpoint Of BICLA Response At Week 48
Brief: Biogen Provides Update On Private Payer Coverage For Zurzuvae™ (Zuranolone)
US RESEARCH ROUNDUP-Eli Lilly, General Dynamics, S&P Global
US RESEARCH ROUNDUP-Baker Hughes, Brinker International, GE Vernova